BackSummary
STERIS plc announces director retirement and appointment, expanding board to ten members with Pierre Boulud.
Key takeaways
- Richard C. Breeden will not stand for reelection, retiring after 18 years of service.
- Board size increased from nine to ten; Pierre Boulud appointed effective May 5, 2026.
- Boulud is CEO of bioMérieux, bringing leadership and operational expertise.
- Boulud receives prorated fee of $76,989 in restricted stock units for remainder of term.
- No disagreement cited for Breeden's departure; orderly board transition.